FDA Adverse Event Injury Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 2071801 · Received April 21, 2011

Report

Report Number
3004464228-2011-00169
Event Type
Injury
Date Received
April 21, 2011
Date of Event
August 21, 2010
Report Date
March 28, 2011
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K042792
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THE POD WAS THOROUGHLY EVALUATED AND NO EVIDENCE OF ANY MALFUNCTION OR MFG DEFICIENCY WAS FOUND THAT WOULD HAVE DIRECTLY CAUSED OR CONTRIBUTED TO THE CUSTOMER'S HIGH BG LEVELS. AN AIR BUBBLE, HOWEVER, WAS FOUND WITHIN THE POD'S INSULIN RESERVOIR. THIS TYPICALLY OCCURS WHEN AIR IS INTRODUCED INTO THE POD DURING THE FILL PROCESS AND IS NOT RELATED TO ANY MFG PROCESS ISSUE OR PRODUCT DEFECT. THE OMNIPOD'S USER GUIDE INSTRUCTS USERS ON PROPER FILLING TECHNIQUE AND INCLUDES THE FOLLOWING WARNING: "NEVER INJECT AIR INTO THE FILL PORT. DOING SO MAY RESULT IN UNINTENDED OR INTERRUPTED INSULIN DELIVERY." INTERRUPTED INSULIN DELIVERY HAS THE POTENTIAL TO RESULT IN HIGH BLOOD GLUCOSE LEVELS. "USER ERROR", THEREFORE, IS CONSIDERED TO BE A CONTRIBUTING FACTOR TO THE CUSTOMER'S REPORTED HIGH BG LEVELS. INSULET HAS INITIATED AN INTERNAL INVESTIGATION TO DETERMINE IF MARKETING CAN IMPROVE EDUCATION AND TRAINING RELATED TO THIS TOPIC. THE INVESTIGATION IS IN-PROCESS AS OF THE DATE OF THIS REPORT.

Description of Event or Problem · 1

THE CUSTOMER'S MOTHER CALLED TO REPORT THAT HER SON EXPERIENCED HIGH BG LEVELS WHILE WEARING THE POD. (NO SPECIFIC LEVELS WERE PROVIDED, BUT BG'S GREATER THAN 250MG/DL ARE ASSUMED.) NO SPECIFIC POD ISSUE WAS REPORTED. NO ADD'L INFO ABOUT THE DEVICE OR THE EVENT WAS PROVIDED. A REQUEST FOR AN UPDATE WAS MADE BUT NOT RECEIVED TO DATE. THE POD WILL BE RETURNED FOR EVAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 11200 L30343

Patients

Seq Age Sex Outcome Treatment
1 17 YR Other